FGFR Inhibitor in FGFR Dysregulated Cancer

Clinical trial NCT03827850 · TERMINATED

Trial details

NCT number: NCT03827850
Sponsor: Lung Cancer Group Cologne
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer NSCLC Pulmonary Neoplasm Squamous Cell Lung Cancer NSCLC Stage IV

Start date: 2019-03-25
Primary completion: 2022-09-30
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.